We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BDSI
2376
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $432K | ﹤0.01% |
41,125
+6,350
| +18% | +$86.8K |
|
2377
Kodak
KODK
$925M
| $431K | ﹤0.01% |
22,685
+300
| +1% | +$5.69K |
|
2378
Mercantile Bank Corp
MBWM
$1.06B
| $431K | ﹤0.01% |
22,047
+1,300
| +6% | +$25.2K |
|
|
AVX
2379
DELISTED
AVX Corporation
AVX
| $431K | ﹤0.01% |
30,229
+130
| +0.4% | +$1.79K |
|
|
ENTR
2380
DELISTED
ENTROPIC COMMUNICATIONS INC COM STK (DE)
ENTR
| $431K | ﹤0.01% |
145,610
+6,700
| +5% | +$18.8K |
|
2381
Motorcar Parts of America
MPAA
$257M
| $430K | ﹤0.01% |
15,470
+2,750
| +22% | +$74.9K |
|
2382
West Bancorporation
WTBA
$483M
| $430K | ﹤0.01% |
21,597
+1,100
| +5% | +$19.2K |
|
|
NETI
2383
DELISTED
Eneti Inc.
NETI
| $430K | ﹤0.01% |
1,625
+92
| +6% | +$22K |
|
|
OMN
2384
DELISTED
OMNOVA Solutions Inc.
OMN
| $430K | ﹤0.01% |
50,430
+9,000
| +22% | +$70.3K |
|
|
MESG
2385
DELISTED
XURA INC COM (DE)
MESG
| $430K | ﹤0.01% |
21,851
+3,500
| +19% | +$64.5K |
|
2386
Camden National
CAC
$992M
| $429K | ﹤0.01% |
16,148
+900
| +6% | +$22.9K |
|
2387
Citizens
CIA
$231M
| $429K | ﹤0.01% |
69,621
+3,300
| +5% | +$23.1K |
|
2388
Digi International
DGII
$3.15B
| $428K | ﹤0.01% |
42,864
+1,600
| +4% | +$15.7K |
|
|
DSPG
2389
DELISTED
DSP Group Inc
DSPG
| $427K | ﹤0.01% |
35,653
+1,500
| +4% | +$16.8K |
|
|
FPRX
2390
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $426K | ﹤0.01% |
18,655
+4,650
| +33% | +$117K |
|
|
FLIC
2391
DELISTED
First of Long Island Corp
FLIC
| $425K | ﹤0.01% |
25,013
+1,200
| +5% | +$19.9K |
|
2392
NACCO Industries
NC
$324M
| $425K | ﹤0.01% |
35,112
+1,313
| +4% | +$16.8K |
|
|
QTS
2393
DELISTED
QTS REALTY TRUST, INC.
QTS
| $425K | ﹤0.01% |
11,665
+3,325
| +40% | +$123K |
|
2394
Phibro Animal Health
PAHC
$1.44B
| $424K | ﹤0.01% |
11,980
+1,650
| +16% | +$53.1K |
|
|
TVPT
2395
DELISTED
Travelport Worldwide Limited
TVPT
| $421K | ﹤0.01% |
25,184
+8,265
| +49% | +$130K |
|
2396
Canadian Imperial Bank of Commerce
CM
$108B
| $420K | ﹤0.01% |
11,580
-126
| -1% | -$4.68K |
|
2397
Nokia
NOK
$52.6B
| $420K | ﹤0.01% |
55,472
+2,500
| +5% | +$19.5K |
|
|
PETX
2398
DELISTED
Aratana Therapeutics, Inc.
PETX
| $420K | ﹤0.01% |
26,240
+5,600
| +27% | +$99.6K |
|
|
CACQ
2399
DELISTED
Caesars Acquisition Company
CACQ
| $420K | ﹤0.01% |
61,760
+3,100
| +5% | +$24K |
|
2400
LendingTree
TREE
$447M
| $419K | ﹤0.01% |
7,483
+700
| +10% | +$33.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.